Use of Bone-Modifying Agents Among Medicare Beneficiaries With Multiple Myeloma.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 31830210.
- Also identified by DOI 10.1001/jamaoncol.2019.5426 and PMC identifier 6990751.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study compares the use of different bone-modifying agents among Medicare beneficiaries with multiple myeloma.
Medical subject headings
- Denosumab
- Insurance Benefits
- Medicare
- Multiple Myeloma